VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ADMA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ADMAADMA Biologics, Inc.
$8.37$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksADMAQuarterly Financials

ADMA Biologics, Inc. (ADMA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ADMA Biologics, Inc. (ADMA) quarterly income statement — complete revenue, gross profit & net income history

ADMA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue114.49M139.16M134.22M121.98M114.8M117.55M119.84M107.19M81.88M73.9M67.28M60.12M56.91M49.98M41.09M33.91M29.1M26.38M20.68M17.83M
Revenue Growth %-0.27%18.39%12%13.8%40.22%59.06%78.13%78.29%43.86%47.86%63.73%77.33%95.56%89.45%98.69%90.15%81.34%89.04%101.24%128.96%
Cost of Goods Sold33.74M50.35M58.6M54.76M53.7M54.22M60.18M49.74M42.77M42.82M42.62M43.43M40.4M35.8M31.43M26.14M25.44M22.87M20.3M18.83M
COGS % of Revenue29.47%36.18%43.66%44.89%46.78%46.12%50.22%46.4%52.23%57.94%63.35%72.24%70.99%71.64%76.5%77.08%87.42%86.69%98.14%105.62%
Gross Profit80.75M88.82M75.63M67.23M61.1M63.33M59.66M57.45M39.11M31.09M24.65M16.69M16.51M14.18M9.66M7.77M3.66M3.51M385.34K-1M
Gross Margin %70.53%63.82%56.34%55.11%53.22%53.88%49.78%53.6%47.77%42.06%36.65%27.76%29.01%28.36%23.5%22.92%12.58%13.31%1.86%-5.62%
Gross Profit Growth %32.17%40.24%26.76%17.01%56.23%103.73%141.99%244.24%136.83%119.27%155.3%114.82%350.92%303.73%2406.02%875.36%312.72%168.12%124.4%82.45%
Operating Expenses29.34M26.07M24.61M24.43M26.22M25.01M20.02M18.25M17.29M16.85M15.97M17.16M17.33M20.24M18.97M16.94M18.48M16.7M14.82M14.58M
OpEx % of Revenue25.63%18.73%18.34%20.03%22.84%21.28%16.71%17.03%21.11%22.8%23.74%28.55%30.44%40.49%46.17%49.98%63.49%63.31%71.67%81.77%
Selling, General & Admin26.74M23.51M23.05M22.21M24.08M23.32M18.56M16.61M15.64M15.53M14.73M14.25M14.51M13.89M12.89M11.97M13.7M11.7M10.73M10.44M
SG&A % of Revenue23.36%16.9%17.17%18.21%20.97%19.84%15.49%15.49%19.1%21.02%21.89%23.7%25.5%27.8%31.38%35.31%47.07%44.34%51.87%58.54%
Research & Development2.6M1.38M1.53M1.03M826K391K412K560K450K445.49K596K1.4M855K1.07M1.04M873.39K624.11K728.99K770.56K1.16M
R&D % of Revenue2.27%0.99%1.14%0.85%0.72%0.33%0.34%0.52%0.55%0.6%0.89%2.33%1.5%2.15%2.54%2.58%2.14%2.76%3.73%6.5%
Other Operating Expenses01000K38K1000K1000K1000K1000K1000K1000K872.7K646K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income58.27M62.75M51.01M42.8M34.88M38.32M39.64M39.2M21.82M14.23M8.69M-473K-813K-6.06M-9.32M-9.17M-14.82M-13.19M-14.44M-15.58M
Operating Margin %50.9%45.09%38.01%35.08%30.38%32.6%33.08%36.57%26.65%19.26%12.91%-0.79%-1.43%-12.12%-22.67%-27.06%-50.91%-50%-69.81%-87.38%
Operating Income Growth %67.07%63.74%28.69%9.18%59.85%169.25%356.4%8387.74%2784.01%334.93%193.22%94.84%94.51%54.07%35.47%41.12%2.3%23.4%-4.61%9.01%
EBITDA58.27M64.8M53.03M44.86M36.85M40.27M41.58M41.25M23.93M16.34M10.78M1.63M1.22M-4.12M-7.45M-7.45M-13.22M-11.67M-13.01M-14.26M
EBITDA Margin %50.9%46.56%39.51%36.77%32.1%34.26%34.69%38.48%29.23%22.11%16.02%2.7%2.14%-8.25%-18.14%-21.97%-45.44%-44.25%-62.93%-79.95%
EBITDA Growth %58.14%60.92%27.56%8.75%53.96%146.4%285.8%2438.34%1861.89%496.49%244.57%121.81%109.23%64.69%42.72%47.74%5.09%26.99%-1.95%12.21%
D&A (Non-Cash Add-back)02.05M2.02M2.06M1.97M1.94M1.94M2.05M2.11M2.11M2.09M2.1M2.03M1.94M1.86M1.72M1.59M1.52M1.42M1.33M
EBIT063.22M49.19M41.93M35.42M37.59M40.25M39.63M22.17M-11.43M8.96M-72K-674K-6.49M-9.32M-9.19M-21.62M-13.33M-14.41M-15.66M
Net Interest Income2.1M-1.14M-1.3M-1.43M-1.37M-2.28M-2.83M-3.33M-3.38M-5.6M-5.97M-5.88M-5.95M-5.73M-5.57M-4.57M-3.36M-3.31M-3.29M-3.24M
Interest Income0487K376K400K608K598K666K449K384K612.45K423.28K414.3K166.97K2.26K7.24K2.27K33.07K2.29K4.26K5.93K
Interest Expense-2.1M1.63M1.68M1.83M1.98M2.88M3.5M3.78M3.77M6.21M6.4M6.3M6.12M5.74M5.58M4.57M3.39M3.32M3.3M3.25M
Other Income/Expense-1.15M-1.16M-3.5M-2.7M-1.43M-3.61M-2.89M-3.35M-3.42M-31.88M-6.12M-5.9M-5.98M-6.17M-5.58M-4.59M-10.19M-3.46M-3.28M-3.32M
Pretax Income57.13M61.59M47.52M40.1M33.45M34.71M36.75M35.85M18.4M-17.64M2.56M-6.37M-6.79M-12.23M-14.9M-13.76M-25.01M-16.65M-17.71M-18.91M
Pretax Margin %49.9%44.26%35.4%32.87%29.14%29.53%30.67%33.45%22.47%-23.88%3.81%-10.6%-11.93%-24.47%-36.26%-40.6%-85.93%-63.11%-85.65%-106.03%
Income Tax11.8M12.22M11.09M5.88M6.55M-77.18M840K3.79M595K00000000000
Effective Tax Rate %20.65%19.83%23.33%14.66%19.57%-222.35%2.29%10.57%3.23%0%0%0%0%0%0%0%0%0%0%0%
Net Income45.33M49.38M36.43M34.22M26.9M111.9M35.91M32.06M17.81M-17.64M2.56M-6.37M-6.79M-12.23M-14.9M-13.76M-25.01M-16.65M-17.71M-18.91M
Net Margin %39.59%35.48%27.14%28.05%23.44%95.19%29.96%29.91%21.75%-23.88%3.81%-10.6%-11.93%-24.47%-36.26%-40.6%-85.93%-63.11%-85.65%-106.03%
Net Income Growth %68.48%-55.87%1.45%6.73%51.1%734.17%1299.96%603.25%362.28%-44.25%117.22%53.72%72.85%26.53%15.88%27.19%-36.06%14.21%-4.7%6.31%
Net Income (Continuing)45.33M49.38M36.43M34.22M26.9M111.9M35.91M32.06M17.81M-17.64M2.56M-6.37M-6.79M-12.23M-14.9M-13.76M-25.01M-16.65M-17.71M-18.91M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.190.200.150.140.110.460.150.130.08-0.080.01-0.03-0.06-0.06-0.10-0.07-0.18-0.09-0.13-0.15
EPS Growth %72.73%-56.52%0%7.69%46.08%688.99%1263.64%554.55%230.96%-29.52%111%59.2%68.06%34.53%23.08%53.27%-12.5%53.95%31.58%34.78%
EPS (Basic)0.190.210.150.140.110.470.150.140.08-0.080.01-0.03-0.06-0.06-0.10-0.07-0.18-0.09-0.13-0.15
Diluted Shares Outstanding239.96M243.85M244.66M248.61M244.68M245.9M244.8M242.17M236.41M225.97M233.76M222.68M221.92M202.83M196.38M196.35M195.87M180.81M133.77M127.42M
Basic Shares Outstanding236.07M237.97M238.6M241.49M237.78M236.43M234.57M232.42M228.87M225.97M225.28M222.68M221.92M202.83M196.38M196.35M195.87M180.81M133.77M126.04M
Dividend Payout Ratio--------------------